Advances in Natural and Applied Sciences Allium sativum
... Desmodium gangeticum (L.) DC. stems and Benincasa hispida (Thunb.) Cogn. leaves on acetic acidinduced gastric pain in mice. Advances in Natural and Applied Sciences, 4: 365-369. Jahan, T., S. Shahreen, J. Banik, F. Islam, A.A. Mamun, R. Das, S. Rahman, S. Seraj, R. Jahan, and M. Rahmatullah, 2011. A ...
... Desmodium gangeticum (L.) DC. stems and Benincasa hispida (Thunb.) Cogn. leaves on acetic acidinduced gastric pain in mice. Advances in Natural and Applied Sciences, 4: 365-369. Jahan, T., S. Shahreen, J. Banik, F. Islam, A.A. Mamun, R. Das, S. Rahman, S. Seraj, R. Jahan, and M. Rahmatullah, 2011. A ...
Fluoxetine-AFT Presentation Fluoxetine hydrochloride equivalent to Fluoxetine 20mg/5mL Oral Liquid
... caregivers of patients) should be alerted about the need to monitor for any worsening of their condition and/or the emergence of suicidal ideation/behaviour or thoughts of harming themselves and to seek medical advice immediately if these symptoms present. Patients with co-morbid depression associat ...
... caregivers of patients) should be alerted about the need to monitor for any worsening of their condition and/or the emergence of suicidal ideation/behaviour or thoughts of harming themselves and to seek medical advice immediately if these symptoms present. Patients with co-morbid depression associat ...
Lateral hypothalamic involvement in feeding elicited from the ventral
... VPm injections by a mean of ~ 55% as compared to control animals they did not completely eliminate it, and every lesioned subject showed slightly higher intakes after ipsilateral bicuculline injections than they did after bilateral saline. While it is possible that this residual response might reflec ...
... VPm injections by a mean of ~ 55% as compared to control animals they did not completely eliminate it, and every lesioned subject showed slightly higher intakes after ipsilateral bicuculline injections than they did after bilateral saline. While it is possible that this residual response might reflec ...
Anticoagulants, Thrombolytics Agents and Antiplatelet Drugs
... Ticlopidine (Ticlid™) and Clopidogrel (Plavix™) ...
... Ticlopidine (Ticlid™) and Clopidogrel (Plavix™) ...
Methadone—metabolism, pharmacokinetics and interactions
... The role of chronic liver diseases in methadone metabolism is not clearly defined. Kreek [30,31] hypothesizes that the abnormal kinetics of methadone that are observed in some patients can be explained by the functional insufficiency of the hepatic microsomal system. The elimination of methadone and ...
... The role of chronic liver diseases in methadone metabolism is not clearly defined. Kreek [30,31] hypothesizes that the abnormal kinetics of methadone that are observed in some patients can be explained by the functional insufficiency of the hepatic microsomal system. The elimination of methadone and ...
Abstract word count: 199 Text word count: 3273
... response to hypercapnia does not continually decrease with progressively greater doses while the analgesic effect is maintained [11, 14, 15, 37-39]. Consequently, it is regarded as a safer opioid compared to methadone. However, buprenorphine is still a highly potent opioid with potentially profound ...
... response to hypercapnia does not continually decrease with progressively greater doses while the analgesic effect is maintained [11, 14, 15, 37-39]. Consequently, it is regarded as a safer opioid compared to methadone. However, buprenorphine is still a highly potent opioid with potentially profound ...
Gastrointestinal issues in autism spectrum disorder. Harv Rev
... Several environmental risk factors have been found to increase the risk for ASD, and a number of these also display interesting links to ASD-related GI abnormalities. Of particular note is maternal immune activation,57 which is regarded as a principal non-genetic cause of autism—based on several lar ...
... Several environmental risk factors have been found to increase the risk for ASD, and a number of these also display interesting links to ASD-related GI abnormalities. Of particular note is maternal immune activation,57 which is regarded as a principal non-genetic cause of autism—based on several lar ...
Calcineurin Inhibitors FK506 and SDZ ASM 981 Alleviate the
... with FK506 at the high dose of 1 mg/kg, injected i.v. 30 min after MCAO, markedly reduced the extent of infarction as assessed by MRI 48 h later. Reduction in T2-weighted signal intensity by FK506 was most prominent in the upper frontoparietal cortex (Fig. 1, C and D) and parietal cortex (data not s ...
... with FK506 at the high dose of 1 mg/kg, injected i.v. 30 min after MCAO, markedly reduced the extent of infarction as assessed by MRI 48 h later. Reduction in T2-weighted signal intensity by FK506 was most prominent in the upper frontoparietal cortex (Fig. 1, C and D) and parietal cortex (data not s ...
Problems of anabolic steroids in sport.
... a sub-committee of a U.S. Senate Committee hearing, “just prior to the 1964 Olympic Games in Tokyo, all around me it seemed that more and more athletes were using steroids for athletic preparation and one began to feel that he was placing himself in a decided disadvantage if he did not also get on ...
... a sub-committee of a U.S. Senate Committee hearing, “just prior to the 1964 Olympic Games in Tokyo, all around me it seemed that more and more athletes were using steroids for athletic preparation and one began to feel that he was placing himself in a decided disadvantage if he did not also get on ...
Tablets and compaction
... Modified-release tablets • should normally be swallowed intact. • The formulation and thus also the type of excipients used in such tablets might be quite different from those of immediate-release tablets. • The drug is released from an extended-release tablet slowly at a nearly constant rate. • If ...
... Modified-release tablets • should normally be swallowed intact. • The formulation and thus also the type of excipients used in such tablets might be quite different from those of immediate-release tablets. • The drug is released from an extended-release tablet slowly at a nearly constant rate. • If ...
12146039
... The potential of solid dispersion based formulation using the combination of PEG6000 and croscarmellose sodium as drug carrier to enhance the dissolution performance and oral bioavailability of Fenofibrate, a poorly water soluble drug was investigated. Fenofibrate is a hydrophobic drug in fibrate cl ...
... The potential of solid dispersion based formulation using the combination of PEG6000 and croscarmellose sodium as drug carrier to enhance the dissolution performance and oral bioavailability of Fenofibrate, a poorly water soluble drug was investigated. Fenofibrate is a hydrophobic drug in fibrate cl ...
Cabergonicht 2 mg tablet ENG SmPC
... Cabergoline is a synthetic ergot alkaloid and an ergoline derivate with long-acting dopamine agonist and prolactin-inhibiting properties. A central dopaminergic effect via D2receptor stimulation is achieved through higher doses than doses that reduce the levels of serum prolactin. Controlled clinic ...
... Cabergoline is a synthetic ergot alkaloid and an ergoline derivate with long-acting dopamine agonist and prolactin-inhibiting properties. A central dopaminergic effect via D2receptor stimulation is achieved through higher doses than doses that reduce the levels of serum prolactin. Controlled clinic ...
Book Review: The Aspirin Wars: Money, Medicine, and 100 Years of
... not only Bayer's physical property in the United States, but also the name Bayer and its symbol, the Bayer cross. The highest bidder was Sterling Products, a West Virginia firm that had previously specialized in the sale of heavily advertised nostrums such as laxatives and cures for impotence. When ...
... not only Bayer's physical property in the United States, but also the name Bayer and its symbol, the Bayer cross. The highest bidder was Sterling Products, a West Virginia firm that had previously specialized in the sale of heavily advertised nostrums such as laxatives and cures for impotence. When ...
Prescribing Information
... Combined usage of MAO inhibitors and reboxetine should be avoided until further data are available due to potential risk (tyramine-like effect) based on their mechanisms of action (See section 4.5 Interaction with other medicinal products and other forms of interaction). Concomitant use of reboxetin ...
... Combined usage of MAO inhibitors and reboxetine should be avoided until further data are available due to potential risk (tyramine-like effect) based on their mechanisms of action (See section 4.5 Interaction with other medicinal products and other forms of interaction). Concomitant use of reboxetin ...
Click Here for the Power Point - Pharmacists Society of the State of
... routine physician prescription of naloxone when opioids were prescribed for pain. • Overdose death rate dropped from 46.6 per 100,000 in 2009 to 29.0 per 100,000 in 2010. • Unpublished data indicates rate of death has continued to drop to 7 deaths per 100,000 is 2011. (2010-2011 rates based on provi ...
... routine physician prescription of naloxone when opioids were prescribed for pain. • Overdose death rate dropped from 46.6 per 100,000 in 2009 to 29.0 per 100,000 in 2010. • Unpublished data indicates rate of death has continued to drop to 7 deaths per 100,000 is 2011. (2010-2011 rates based on provi ...
America`s Favorite Drug - American Medical Technologists
... eliminated. Oddly, women metabolize it about 25% faster than men. Some studies have shown use causes a physical dependence, though tolerance can be different for different users. Typical withdrawal symptoms are headache, fatigue, muscle pain and negative mood or irritability. These symptoms can occu ...
... eliminated. Oddly, women metabolize it about 25% faster than men. Some studies have shown use causes a physical dependence, though tolerance can be different for different users. Typical withdrawal symptoms are headache, fatigue, muscle pain and negative mood or irritability. These symptoms can occu ...
The Second Messenger cAMP Elicits Eating by an Anatomically
... Figure 1. Photomicrographs of coronal sections stained with cresyl violet showing representative injection sites, indicated by arrows, located in A, G, lateral hypothalamus (LH ); B, paraventricular nucleus of the hypothalamus (PV N ); C, perifornical hypothalamus (PFH ); D, posterior lateral hypoth ...
... Figure 1. Photomicrographs of coronal sections stained with cresyl violet showing representative injection sites, indicated by arrows, located in A, G, lateral hypothalamus (LH ); B, paraventricular nucleus of the hypothalamus (PV N ); C, perifornical hypothalamus (PFH ); D, posterior lateral hypoth ...
Management of Medication Induced Xerostomia An Evidence Based
... always, associated with altered salivary quantity and/or quality. Dry mouth can be caused by the destruction of the salivary glands from radiotherapy to the head and neck region or by an autoimmune disease known as Sjogren’s syndrome. However, the most common cause of xerostomia is from the use of x ...
... always, associated with altered salivary quantity and/or quality. Dry mouth can be caused by the destruction of the salivary glands from radiotherapy to the head and neck region or by an autoimmune disease known as Sjogren’s syndrome. However, the most common cause of xerostomia is from the use of x ...
Pharmacologic therapy of cancer pain
... pain location are also included in the MPQ. The disadvantage of the MPQ is that it is not self-administered, and takes up to 20 minutes to complete. A shorter instrument, the Memorial Pain Assessment Card, is designed to allow rapid assessment of cancer pain intensity, effectiveness of analgesics, a ...
... pain location are also included in the MPQ. The disadvantage of the MPQ is that it is not self-administered, and takes up to 20 minutes to complete. A shorter instrument, the Memorial Pain Assessment Card, is designed to allow rapid assessment of cancer pain intensity, effectiveness of analgesics, a ...
Pharmacokinetic/Pharmacodynamic Parameters: Rationale
... because of the design of most clinical trials. Most studies evaluating the efficacy of different dosage regimens compare two or more dose levels of drug administered at the same dosing interval. As shown in the left panel of figure 3, a fourfold-higher dose produces a higher peak/MIC ratio, a higher ...
... because of the design of most clinical trials. Most studies evaluating the efficacy of different dosage regimens compare two or more dose levels of drug administered at the same dosing interval. As shown in the left panel of figure 3, a fourfold-higher dose produces a higher peak/MIC ratio, a higher ...
Dosage Form Design: Pharmaceutical and Formulation
... the size, shape, and color of solid dosage forms, the easier is proper identification of the medications. Errors in taking medications among the elderly occur frequently because of their multiple drug therapy and impaired eyesight. Dosage forms that allow reduced frequency of administration without ...
... the size, shape, and color of solid dosage forms, the easier is proper identification of the medications. Errors in taking medications among the elderly occur frequently because of their multiple drug therapy and impaired eyesight. Dosage forms that allow reduced frequency of administration without ...
Ina AIHA
... PCH – caused by biphasic Ig G auto a/b ( fix C at cold T and dissociate at higher T) ( Donath Landsteiner a/b) ...
... PCH – caused by biphasic Ig G auto a/b ( fix C at cold T and dissociate at higher T) ( Donath Landsteiner a/b) ...
Psychopharmacology
Psychopharmacology (from Greek ψῡχή, psȳkhē, ""breath, life, soul""; φάρμακον, pharmakon, ""drug""; and -λογία, -logia) is the scientific study of the effects drugs have on mood, sensation, thinking, and behavior. It is distinguished from neuropsychopharmacology, which emphasizes the correlation between drug-induced changes in the functioning of cells in the nervous system and changes in consciousness and behavior.The field of psychopharmacology studies a wide range of substances with various types of psychoactive properties, focusing primarily on the chemical interactions with the brain.Psychoactive drugs interact with particular target sites or receptors found in the nervous system to induce widespread changes in physiological or psychological functions. The specific interaction between drugs and their receptors is referred to as ""drug action"", and the widespread changes in physiological or psychological function is referred to as ""drug effect"". These drugs may originate from natural sources such as plants and animals, or from artificial sources such as chemical synthesis in the laboratory.